D-0109-2025 Class II Ongoing
FDA drug recall D-0109-2025 was initiated by AvKARE on Nov 27, 2024 and is designated Class II. Reason for recall: CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit. The recall status is ongoing. Affected quantity: 2,396 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 11, 2024
- Initiation Date
- Nov 27, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,396 bottles
Product description
Cinacalcet Tablets, 60 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 42291-460-30
Reason for recall
CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinacalcet above acceptable intake limit.
Distribution pattern
USA Nationwide
Code information
Lot # 44550, Exp 12/31/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0109-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026